Page last updated: 2024-11-02
picotamide and Raynaud Disease
picotamide has been researched along with Raynaud Disease in 1 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Pancera, P | 1 |
Sansone, S | 1 |
Secchi, S | 1 |
Covi, G | 1 |
Lechi, A | 1 |
Trials
1 trial available for picotamide and Raynaud Disease
Article | Year |
---|---|
The effects of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon.
Topics: Adolescent; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood | 1997 |